Crossref
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
The Brown University Child & Adolescent Psychopharmacology Update · 2026-04 · 28 (4) · 7-7
DOI: 10.1002/cpu.31055 ↗At a glance
Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-03-23. Written by Alison Knopf.
Abstract (original language)
Nenhum resumo disponível.
Cite
APA
Knopf, A. (2026). 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update, 28(4), 7-7. https://doi.org/10.1002/cpu.31055
Vancouver
Knopf A. 2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(4):7-7. doi:10.1002/cpu.31055
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency},
journal = {The Brown University Child & Adolescent Psychopharmacology Update},
year = {2026},
volume = {28},
number = {4},
pages = {7--7},
doi = {10.1002/cpu.31055}
}
EUVIMED